Accelrys Announces the Appointment of Rohit Shyam as Vice President, Corporate Development and Strategy

Accelrys, Inc. (NASDAQ:ACCL) a leading provider of scientific business intelligence solutions announced today the appointment of Rohit Shyam as Vice President, Corporate Development and Strategy. Most recently, Mr. Shyam served as Partner, Senior Strategy Expert, and Solution Director for Computer Sciences Corporation in the Global Health Solutions sector. In his role at Computer Sciences Corporation Mr. Shyam developed and delivered solutions that addressed industry trends and challenges in pharmaceuticals, biotech, agri-biotech and medical devices. Prior to joining Computer Sciences Corporation, Mr. Shyam was a Principal at IBM, where he helped launch its life sciences practice. He also led strategic consulting initiatives as a Principal at Booz Allen Hamilton and has had success as a start-up company entrepreneur. Commenting on Mr. Shyam’s appointment, Mark J. Emkjer, Accelrys’ President and Chief Executive Officer, said: "Accelrys is at the point where we need someone to focus full time on corporate development, mergers and acquisitions and strategy. Rohit’s background and expertise in the life science market and understanding of the applications of business intelligence software make him an excellent choice for this role.” Mr. Shyam holds a B.S. in Computer Engineering from Lehigh University and an M.B.A. from The Kellogg School of Management at Northwestern University. About Accelrys, Inc. Accelrys develops and commercializes scientific business intelligence software for the integration, mining, analysis, modeling and simulation, management and interactive reporting of scientific data. Our solutions are used by biologists, chemists, materials scientists, and information technology professionals for product design as well as drug discovery and development. Our technology and services are designed to meet the needs of today’s leading research and development organizations including leading commercial, government and academic organizations. Many of the largest pharmaceutical, biotechnology, chemical, and petroleum companies worldwide use our solutions. Accelrys is headquartered in San Diego, California. For more information about Accelrys, visit its website at http://www.accelrys.com/ Forward-Looking Statements This press release contains forward-looking statements. Such statements, including statements relating to the potential mergers, acquisitions and the Company’s scientific business intelligence strategy, and the implementation thereof, are subject to risks and uncertainties including, but not limited to, the risks that the such mergers, acquisitions or Company’s strategy will not be successful, and other risks and uncertainties described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K and any subsequent interim filings. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys disclaims any intent or obligation to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.